Results of initial operations in non-small cell lung cancer patients with single-level N2 disease

被引:28
作者
Ohta, Y [1 ]
Shimizu, Y [1 ]
Minato, H [1 ]
Matsumoto, I [1 ]
Oda, M [1 ]
Watanabe, G [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan
关键词
D O I
10.1016/j.athoracsur.2005.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. There is still debate regarding the use of surgery in the management of non-small cell lung cancer patients with N2 disease. The primary aim of the present study was analysis of the results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Methods. Ninety-four patients with the disease who underwent initial surgery consisting of complete resection of the primary site plus systematic lymphadenectomy were examined. We also immunohistochemically examined lymphatic vessel density and vascular endothelial growth factor-C expression. Results. The overall 5- and 10-year survival rates for the 94 patients were 27.1% and 12.1%, respectively, with a median survival of 22 months. When stratified by skipping status, the 5-year survival rates for the patients in skip-N2 and non-skip-N2 groups were 33.4% and 19.8%, respectively (p = 0.0189). Skip metastasis, T factor, sub-carinal lymph node metastasis, and adjuvant chemotherapy were recognized as independent prognostic indicators. In both skip-N2 and non-skip-N2 groups, distant relapse was the dominant pattern of recurrence. Although the peritumoral lymphatic vessel density was associated with vascular endothelial growth factor-C expression in tumors, the lymphangiogenic profile appeared to be different between skip-N2 and non-skip-N2 tumors, suggesting different nodal metastatic process. Conclusions. Lung cancer patients with single-level N2 disease are an oncologically heterogeneous cohort. Although further studies involving randomized comparisons are required, the poor outcomes found here indicate that the initial operation has yet to be validated for patients with this disease.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 32 条
[1]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[2]   Tumor lymphangiogenesis - A novel prognostic indicator for cutaneous melanoma metastasis and survival [J].
Dadras, SS ;
Paul, T ;
Bertoncini, J ;
Brown, LF ;
Muzikansky, A ;
Jackson, DG ;
Ellwanger, U ;
Garbe, C ;
Mihm, MC ;
Detmar, M .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1951-1960
[3]   Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms [J].
Faries, MB ;
Bleicher, R ;
Ye, XN ;
Essner, R ;
Morton, DL .
ARCHIVES OF SURGERY, 2004, 139 (08) :870-876
[4]   Tumor lymphangiogenesis in head and neck squamous cell carcinoma - A morphometric study with clinical correlations [J].
Franchi, A ;
Gallo, O ;
Massi, D ;
Baroni, G ;
Santucci, M .
CANCER, 2004, 101 (05) :973-978
[5]   Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases [J].
Fukuse, T ;
Hirata, T ;
Naiki, H ;
Hitomi, S ;
Wada, H .
ANNALS OF SURGERY, 2000, 232 (01) :112-118
[6]  
International Union against Cancer, 1997, TNM CLASS MAL TUM, P93
[7]   A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors [J].
Kahn, HJ ;
Marks, A .
LABORATORY INVESTIGATION, 2002, 82 (09) :1255-1257
[8]   Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas [J].
Kahn, HJ ;
Bailey, D ;
Marks, A .
MODERN PATHOLOGY, 2002, 15 (04) :434-440
[9]   The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer [J].
Kajita, T ;
Ohta, Y ;
Kimura, K ;
Tamura, M ;
Tanaka, Y ;
Tsunezuka, Y ;
Oda, M ;
Sasaki, T ;
Watanabe, G .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :255-260
[10]   Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease [J].
Keller, SM ;
Vangel, MG ;
Wagner, H ;
Schiller, JH ;
Herskovic, A ;
Komaki, R ;
Marks, RS ;
Perry, MC ;
Livingston, RB ;
Johnson, DH .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 128 (01) :130-137